Hansa Biopharma AB
Hansa Biopharma AB is a Private limited company (Ltd.) registered in Sweden under 5567345359, and its current status with Swedish Companies Registration Office (Bolagsverket) is active. The company was incorporated on 10 July 2007 and lists its registered address as Lund, Sweden. 5 shareholders are on record for Hansa Biopharma AB, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Swedish Companies Registration Office (Bolagsverket) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Hansa Biopharma AB, filed with Swedish Companies Registration Office (Bolagsverket).
The largest of these is Fidelity Select Portfolios-Select Biotechnology Portfolio, holding 76.4% — a majority holding — followed by SPDR INDEX SHARES FUNDS-SPDR Portfolio Developed World ex-US ETF at 10.4%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 7 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 76.4% | Swedish Companies Registration Office (Bolagsverket) | |
| SPDR INDEX SHARES FUNDS-SPDR Portfolio Developed World ex-US ETF | 10.4% | Swedish Companies Registration Office (Bolagsverket) | |
| SPDR Portfolio Developed World ex-US ETF | 7.1% | Swedish Companies Registration Office (Bolagsverket) | |
| SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF | 2.3% | Swedish Companies Registration Office (Bolagsverket) | |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 2.3% | Swedish Companies Registration Office (Bolagsverket) |
Officers
5
Two of the 5 officer records shown for Hansa Biopharma AB are current appointments, filed with Swedish Companies Registration Office (Bolagsverket). Fredrik Emanuel Björne and Folke Per-Olof Wallström both serve as Director. The remaining 3 records shown (Ulf Pontus Bogren, Bo Erik Berggren and 1 other) are former appointments that have since been resigned.
The register reports 28 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Hansa Biopharma AB sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Hansa Biopharma AB has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 4 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 5 subsidiaries span Sweden, Norway, Italy, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 5 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Hansa Biopharma AB
Sweden
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Hansa Biopharma AB?
Five shareholders are currently on record for Hansa Biopharma AB, filed with Swedish Companies Registration Office (Bolagsverket). The largest of these is Fidelity Select Portfolios-Select Biotechnology Portfolio, holding 76.4% — a majority holding — followed by SPDR INDEX SHARES FUNDS-SPDR Portfolio Developed World ex-US ETF at 10.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Hansa Biopharma AB's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Hansa Biopharma AB is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Hansa Biopharma AB have on record?
5 shareholders are shown on record for Hansa Biopharma AB. The register reports 7 in total; only the top 5 by holding are shown here.
What is Hansa Biopharma AB's company registration number?
Hansa Biopharma AB's registration number is 5567345359, filed with Swedish Companies Registration Office (Bolagsverket) in Sweden. Its current status on the register is active.
Is Hansa Biopharma AB still an active company?
Hansa Biopharma AB's status on Swedish Companies Registration Office (Bolagsverket) is listed as active.
When was Hansa Biopharma AB incorporated?
Hansa Biopharma AB was incorporated on 10 July 2007, according to Swedish Companies Registration Office (Bolagsverket).
What is Hansa Biopharma AB's registered address?
The registered address on file for Hansa Biopharma AB is Lund, Sweden.
What legal structure is Hansa Biopharma AB registered as?
Hansa Biopharma AB is registered as a Private limited company (Ltd.) in Sweden.
Who are the officers/directors of Hansa Biopharma AB?
Two of the 5 officer records shown for Hansa Biopharma AB are current appointments, filed with Swedish Companies Registration Office (Bolagsverket). Fredrik Emanuel Björne and Folke Per-Olof Wallström both serve as Director. The remaining 3 records shown (Ulf Pontus Bogren, Bo Erik Berggren and 1 other) are former appointments that have since been resigned. Management authority at Hansa Biopharma AB sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Hansa Biopharma AB have a parent company or subsidiaries?
Hansa Biopharma AB has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 4 jurisdictions. Those 5 subsidiaries span Sweden, Norway, Italy, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 5 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Hansa Biopharma AB's ownership over time?
This profile reflects a point-in-time snapshot from Swedish Companies Registration Office (Bolagsverket). Zavia's monitoring API can track changes to Hansa Biopharma AB's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Hansa Biopharma AB's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Sweden, so records like Hansa Biopharma AB's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Swedish Companies Registration Office (Bolagsverket) and was last synced on 28 September 2026.